Valuation: PharmaEssentia Corporation

Capitalization 293B 9.28B 7.97B 7.29B 6.9B 12.74B 896B 12.98B 86.56B 33.83B 424B 34.83B 34.08B 1,474B P/E ratio 2026 *
34.1x
P/E ratio 2027 * 20.7x
Enterprise value 269B 8.5B 7.3B 6.68B 6.32B 11.67B 821B 11.89B 79.29B 30.99B 388B 31.9B 31.22B 1,351B EV / Sales 2026 *
10.8x
EV / Sales 2027 * 7.28x
Free-Float
77.43%
Yield 2026 *
0.27%
Yield 2027 * 0.25%
1 day-0.88%
1 week+10.97%
Current month+19.36%
1 month+20.83%
3 months+8.83%
6 months+73.98%
Current year+67.87%
1 week 772
Extreme 772
859
1 month 578
Extreme 578
859
Current year 470
Extreme 470
859
1 year 428.03
Extreme 428.0317
859
3 years 246.91
Extreme 246.9067
859
5 years 62.18
Extreme 62.1772
859
10 years 48.3
Extreme 48.3
859
Manager TitleAgeSince
Chief Executive Officer - 2002-12-31
Director of Finance/CFO - 2015-10-13
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2003-08-31
Director/Board Member - -
Director/Board Member - 2009-06-29
Change 5d. change 1-year change 3-years change Capi.($)
-0.88%+10.97%+74.07%+176.21% 9.33B
+0.79%-1.12%+36.17%+78.77% 49.39B
+1.29%-6.55%+68.88%+53.42% 45.18B
+0.47%-6.97%+58.97%+454.52% 23.28B
+2.93%-3.52%-7.61%-15.15% 22.2B
+0.42%-1.66%+39.54%-21.38% 17.43B
+3.95%+0.58%+30.49%-38.96% 15.79B
+1.95%-11.54%+37.64%+205.85% 13.26B
+1.72%-5.16%+32.02% - 12.79B
+12.87%-5.59%-25.49%+964.88% 12.3B
Average +2.55%-4.94%+34.47%+206.46% 22.1B
Weighted average by Cap. +2.00%-3.86%+38.74%+152.80%

Financials

2026 *2027 *
Net sales 24.87B 787M 676M 619M 585M 1.08B 76.04B 1.1B 7.34B 2.87B 35.93B 2.95B 2.89B 125B 36.84B 1.17B 1B 917M 867M 1.6B 113B 1.63B 10.88B 4.25B 53.21B 4.38B 4.28B 185B
Net income 8.8B 279M 239M 219M 207M 383M 26.91B 390M 2.6B 1.02B 12.72B 1.05B 1.02B 44.27B 14.29B 452M 389M 356M 336M 621M 43.69B 633M 4.22B 1.65B 20.64B 1.7B 1.66B 71.86B
Net Debt -24.62B -779M -669M -612M -579M -1.07B -75.25B -1.09B -7.27B -2.84B -35.55B -2.92B -2.86B -124B -24.86B -787M -676M -618M -585M -1.08B -76.01B -1.1B -7.34B -2.87B -35.91B -2.95B -2.89B -125B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
26-05-20 789.00 NT$ -0.88% 3,260,105
26-05-19 796.00 NT$ -1.24% 3,574,884
26-05-18 806.00 NT$ -2.42% 4,545,275
26-05-15 826.00 NT$ +5.63% 6,962,306
26-05-14 782.00 NT$ 0.00% 6,655,502
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
789.00TWD
Average target price
778.83TWD
Spread / Average Target
-1.29%

Quarterly revenue - Rate of surprise